Vallon Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Philadelpia PA United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04232644
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Vallon Pharmaceuticals, Inc.